Currently holds positions in Invitae Corp and BridgeBio Pharma Inc
Position | Company | Period |
---|---|---|
Executive Chairman of the Board | Invitae Corp | Jan. 9, 2017 - |
Independent Director | BridgeBio Pharma Inc | June 23, 2020 - |
Executive Chairman of the Board | Invitae Corp | Jan. 9, 2017 - Sept. 1, 2019 |
Chairman of the Board, Chief Executive Officer | Invitae Corp | Aug. 1, 2012 - Jan. 9, 2017 |
Chief Executive Officer of InVitae Corporation, Director | Genomic Health Inc | March 1, 2012 - Aug. 8, 2012 |
Director | Invitae Corp | Jan. 1, 2010 - Aug. 1, 2012 |
Executive Chairman of the Board | Genomic Health Inc | Jan. 1, 2009 - March 1, 2012 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-05 | 2024-03-01 |
BridgeBio Pharma Inc
(BBIO)
|
PS Planned sale |
2,500
-27.8%
34.0085,000 USD |
2,500 -27.8% | 34.00 | 85,000 USD | |
2023-12-20 | 2023-12-18 |
BridgeBio Pharma Inc
(BBIO)
|
PS Planned sale |
2,000
-18.2%
40.0080,000 USD |
2,000 -18.2% | 40.00 | 80,000 USD | |
2023-09-07 | 2023-09-05 |
BridgeBio Pharma Inc
(BBIO)
|
PS Planned sale |
2,500
-15.6%
30.0075,000 USD |
2,500 -15.6% | 30.00 | 75,000 USD | |
2021-05-18 | 2021-05-17 |
Talis Biomedical Corp
(TLIS)
|
B Purchase |
11,000
+122.2%
10.11111,210 USD |
11,000 +122.2% | 10.11 | 111,210 USD | |
2021-05-18 | 2021-05-14 |
Talis Biomedical Corp
(TLIS)
|
B Purchase |
9,000
+inf%
10.1691,440 USD |
9,000 +inf% | 10.16 | 91,440 USD | |
2021-02-19 | 2021-02-17 |
Talis Biomedical Corp
(TLIS)
|
B Purchase |
312,500
+inf%
16.005,000,000 USD |
312,500 +inf% | 16.00 | 5,000,000 USD | |
2021-02-18 | 2021-02-17 |
BridgeBio Pharma Inc
(BBIO)
|
B Purchase |
16,000
+320.0%
62.501,000,000 USD |
16,000 +320.0% | 62.50 | 1,000,000 USD | |
2019-05-30 | 2019-05-28 |
Invitae Corp
(NVTA)
|
PS Planned sale |
30,000
-0.9%
17.60528,027 USD |
30,000 -0.9% | 17.60 | 528,027 USD | |
2019-02-27 | 2019-02-25 |
Invitae Corp
(NVTA)
|
PS Planned sale |
1,000
-0.0%
19.6619,657 USD |
1,000 -0.0% | 19.66 | 19,657 USD | |
2019-02-27 | 2019-02-25 |
Invitae Corp
(NVTA)
|
PS Planned sale |
29,000
-0.8%
19.08553,340 USD |
29,000 -0.8% | 19.08 | 553,340 USD |